Cargando…
Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis
Autores principales: | Moll, Matthew, Zon, Rebecca L., Sylvester, Katelyn W., Rimsans, Jessica, Chen, Evan C., Ghosh, Auyon J., Abston, Eric, Kim, Andy, Rutherford, Henry, Mitre, Xhoi, Hakim, Aaron, Connell, Nathan T., Battinelli, Elisabeth, Fredenburgh, Laura E., Baron, Rebecca M., Hobbs, Brian D., Cho, Michael H., Mittleman, Murray A., Woolley, Ann E., Connors, Jean M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053596/ https://www.ncbi.nlm.nih.gov/pubmed/33940309 http://dx.doi.org/10.1016/j.thromres.2021.04.009 |
Ejemplares similares
-
VTE in ICU Patients With COVID-19
por: Moll, Matthew, et al.
Publicado: (2020) -
Heparin‐induced thrombocytopenia in end‐stage renal disease: Reliability of the PF4‐heparin ELISA
por: Kelly, Julie, et al.
Publicado: (2021) -
Evaluation of Antifactor-Xa Heparin Assay and Activated Partial
Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated
Heparin Therapy
por: McLaughlin, Kevin, et al.
Publicado: (2019) -
When to use anticoagulation in COVID-19()()
por: Moll, Matthew, et al.
Publicado: (2021) -
Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients
por: Preti, Paola S., et al.
Publicado: (2021)